ProfileGDS4718 / 229032_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 60% 84% 60% 61% 59% 58% 60% 56% 55% 59% 52% 60% 54% 62% 52% 57% 55% 60% 60% 65% 61% 57% 60% 58% 56% 56% 53% 51% 60% 62% 61% 60% 50% 55% 56% 59% 63% 58% 80% 52% 59% 64% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0694159
GSM549102patient 115, normal, homogenized [OPG study]6.1204260
GSM549104patient 119, normal, homogenized [OPG study]8.4167184
GSM549108patient 138, normal, homogenized [OPG study]6.1253360
GSM549119patient 077, normal, homogenized [OPG study]6.1583461
GSM549133patient 032, cancer, homogenized [OPG study]6.0183859
GSM549139patient 042, cancer, homogenized [OPG study]5.9613758
GSM549099patient 107, normal, homogenized [OPG study]6.1228160
GSM549109patient 139, normal, homogenized [OPG study]5.8920556
GSM549110patient 046, normal, homogenized [OPG study]5.8217855
GSM549114patient 063, normal, homogenized [OPG study]6.0196959
GSM549122patient 082, normal, homogenized [OPG study]5.6198152
GSM549134patient 033, cancer, homogenized [OPG study]6.1196760
GSM549136patient 036, cancer, homogenized [OPG study]5.7329254
GSM549140patient 044, cancer, homogenized [OPG study]6.2565862
GSM549111patient 047, normal, homogenized [OPG study]5.596852
GSM549113patient 057, normal, homogenized [OPG study]5.9070757
GSM549132patient 031, cancer, homogenized [OPG study]5.7773255
GSM549137patient 038, cancer, homogenized [OPG study]6.1057760
GSM549142patient 047, cancer, homogenized [OPG study]6.2292560
GSM549100patient 110, normal, homogenized [OPG study]6.461165
GSM549107patient 135, normal, homogenized [OPG study]6.1884961
GSM549115patient 068, normal, homogenized [OPG study]5.9208657
GSM549116patient 072, normal, homogenized [OPG study]6.1308260
GSM549120patient 078, normal, homogenized [OPG study]5.9909858
GSM549131patient 030, cancer, homogenized [OPG study]5.8607456
GSM549118patient 074, normal, homogenized [OPG study]5.8446456
GSM549129patient 027, cancer, homogenized [OPG study]5.7328953
GSM549123patient 088, normal, homogenized [OPG study]5.5620251
GSM549124patient 006, cancer, homogenized [OPG study]6.1475960
GSM549126patient 015, cancer, homogenized [OPG study]6.2276862
GSM549128patient 025, cancer, homogenized [OPG study]6.2193161
GSM549103patient 117, normal, homogenized [OPG study]6.1569760
GSM549117patient 073, normal, homogenized [OPG study]5.4741850
GSM549138patient 041, cancer, homogenized [OPG study]5.7876155
GSM549141patient 045, cancer, homogenized [OPG study]5.8479856
GSM549130patient 028, cancer, homogenized [OPG study]6.0475759
GSM549101patient 111, normal, homogenized [OPG study]6.3795563
GSM549105patient 128, normal, homogenized [OPG study]5.9838958
GSM549106patient 134, normal, homogenized [OPG study]8.0650380
GSM549112patient 048, normal, homogenized [OPG study]5.6251452
GSM549125patient 011, cancer, homogenized [OPG study]6.0782859
GSM549127patient 024, cancer, homogenized [OPG study]6.4428864
GSM549135patient 035, cancer, homogenized [OPG study]5.8033255